Skip to content

IVERIC bio, Inc.

CIK 0001410939

← back to feed
Revenue (TTM)
$208.32M
Q1 May 2023
Net Income (TTM)
−$198.38M
−61.7% YoY Q1 May 2023
EPS Diluted (TTM)
−$1.58
−36.6% YoY Q1 May 2023
Gross Margin
—
Q1 May 2023
Operating Margin
-96.4%
Q1 May 2023
Net Margin
-95.2%
Q1 May 2023
Free Cash Flow (TTM)
−$135.44M
Q1 May 2023
Cash
$467.57M
Q1 May 2023
Total Debt
$96.99M
Q1 May 2023
Shares Outstanding
137.78M sh
Q1 May 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings